Thomas Olin

528 total citations
28 papers, 322 citations indexed

About

Thomas Olin is a scholar working on Molecular Biology, Immunology and Aquatic Science. According to data from OpenAlex, Thomas Olin has authored 28 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Immunology and 7 papers in Aquatic Science. Recurrent topics in Thomas Olin's work include PI3K/AKT/mTOR signaling in cancer (8 papers), Aquaculture Nutrition and Growth (7 papers) and Reproductive biology and impacts on aquatic species (7 papers). Thomas Olin is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (8 papers), Aquaculture Nutrition and Growth (7 papers) and Reproductive biology and impacts on aquatic species (7 papers). Thomas Olin collaborates with scholars based in Sweden, Iran and Greece. Thomas Olin's co-authors include Alexandra von der Decken, Johan Schultz, Mohammad Hojjat‐Farsangi, Anders Österborg, Ali Moshfegh, Håkan Mellstedt, Amir Hossein Daneshmanesh, Parviz Kokhaei, Lotta Hansson and Martin Norin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Thomas Olin

28 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Olin Sweden	11	122	84	83	83	58	28	322
Dipanjan Basu United States	14	309 2.5×	54 0.6×	135 1.6×	84 1.0×	38 0.7×	23	644
Yongli Lou China	10	131 1.1×	59 0.7×	21 0.3×	97 1.2×	34 0.6×	15	364
David Corrigan United States	6	228 1.9×	49 0.6×	41 0.5×	47 0.6×	112 1.9×	8	467
Utkrisht Rajkumar India	8	368 3.0×	56 0.7×	117 1.4×	48 0.6×	16 0.3×	21	600
Magali Navarro United States	10	340 2.8×	82 1.0×	46 0.6×	23 0.3×	65 1.1×	11	490
Michelle Lion Belgium	12	436 3.6×	74 0.9×	45 0.5×	55 0.7×	64 1.1×	17	657
Chiara Zucal Italy	13	435 3.6×	18 0.2×	69 0.8×	34 0.4×	56 1.0×	18	592
Kirsten M. Spoorendonk Netherlands	5	328 2.7×	30 0.4×	25 0.3×	24 0.3×	47 0.8×	5	523
J. Renn Singapore	10	295 2.4×	47 0.6×	25 0.3×	18 0.2×	52 0.9×	19	482
Melissa A. Stolow United States	8	405 3.3×	37 0.4×	122 1.5×	40 0.5×	81 1.4×	8	724

Countries citing papers authored by Thomas Olin

Since Specialization

Citations

This map shows the geographic impact of Thomas Olin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Olin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Olin more than expected).

Fields of papers citing papers by Thomas Olin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Olin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Olin. The network helps show where Thomas Olin may publish in the future.

Co-authorship network of co-authors of Thomas Olin

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Olin. A scholar is included among the top collaborators of Thomas Olin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Olin. Thomas Olin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kokhaei, Parviz, Ali Moshfegh, Jeanette Lundin, et al.. (2024). A Small Molecule Antagonist of CX3CR1 (KAND567) Inhibited the Tumor Growth-Promoting Effect of Monocytes in Chronic Lymphocytic Leukemia (CLL). Cancers. 16(22). 3821–3821. 3 indexed citations

Hojjat‐Farsangi, Mohammad, Ann Svensson, Jeanette Lundin, et al.. (2023). A CX3CR1 (fractalkine receptor) Small Molecular Antagonist (KAND567) Suppressed the Growth Promoting Effect of Monocytes on Chronic Lymphocytic Leukemia Cells. Blood. 142(Supplement 1). 5716–5716. 1 indexed citations

Olin, Thomas, et al.. (2023). Fractalkine Signalling (CX3CL1/CX3CR1 Axis) as an Emerging Target in Coronary Artery Disease. Journal of Clinical Medicine. 12(14). 4821–4821. 18 indexed citations

Petris, Luigi De, Parviz Kokhaei, Georgios Z. Rassidakis, et al.. (2023). A Small Molecule Targeting the Intracellular Tyrosine Kinase Domain of ROR1 (KAN0441571C) Induced Significant Apoptosis of Non-Small Cell Lung Cancer (NSCLC) Cells. Pharmaceutics. 15(4). 1148–1148. 8 indexed citations

Hojjat‐Farsangi, Mohammad, Ali Moshfegh, Johan Schultz, et al.. (2021). Targeting the Receptor Tyrosine Kinase ROR1 by Small Molecules. Handbook of experimental pharmacology. 269. 75–99. 6 indexed citations

Svensson, Ann, Marzia Palma, Johan Schultz, et al.. (2021). A ROR1 small molecule inhibitor (KAN0441571C) induced significant apoptosis of ibrutinib‐resistant ROR1⁺ CLL cells. SHILAP Revista de lepidopterología. 2(3). 498–502. 9 indexed citations

Daneshmanesh, Amir Hossein, Ali Moshfegh, Parviz Kokhaei, et al.. (2020). ROR1 is Expressed in Diffuse Large B-Cell Lymphoma (DLBCL) and a Small Molecule Inhibitor of ROR1 (KAN0441571C) Induced Apoptosis of Lymphoma Cells. Biomedicines. 8(6). 170–170. 29 indexed citations

Hojjat‐Farsangi, Mohammad, Ali Moshfegh, Parviz Kokhaei, et al.. (2019). Diffuse Large B Cell Lymphoma (DLBCL) Expresses ROR1 and a ROR1 Small Molecule Inhibitor (KAN0441571C) Induced Significant Apoptosis of Tumor Cells. Blood. 134(Supplement_1). 2565–2565. 5 indexed citations

Hojjat‐Farsangi, Mohammad, Amir Hossein Daneshmanesh, Abdul Salam Khan, et al.. (2018). First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cells. Leukemia. 32(10). 2291–2295. 38 indexed citations

10.

Daneshmanesh, Amir Hossein, Mohammad Hojjat‐Farsangi, Ali Moshfegh, et al.. (2018). A receptor tyrosine kinase ROR1 inhibitor (KAN0439834) induced significant apoptosis of pancreatic cells which was enhanced by erlotinib and ibrutinib. PLoS ONE. 13(6). e0198038–e0198038. 31 indexed citations

11.

Hojjat‐Farsangi, Mohammad, Amir Hossein Daneshmanesh, Fariba Mozaffari, et al.. (2017). First-in-Class Oral Small Molecule Against the Tyrosine Kinase ROR1 (KAN0439834) Induced Significant Apoptosis of Chronic Lymphocytic Leukemia Cells. Blood. 130. 4320–4320. 1 indexed citations

12.

Mellstedt, Håkan, Mohammad Hojjat‐Farsangi, Amir Hossein Daneshmanesh, et al.. (2016). First generation of a small chemical molecule ROR1 RTK tyrosine kinase inhibitor. Annals of Oncology. 27. vi530–vi530. 3 indexed citations

13.

Mellstedt, Håkan, Mohammad Hojjat‐Farsangi, Amir Hossein Daneshmanesh, et al.. (2015). A new class of anti-cancer drugs targeting the tyrosine kinase receptor ROR1 in CLL.. Journal of Clinical Oncology. 33(15_suppl). 8556–8556. 3 indexed citations

14.

Hojjat‐Farsangi, Mohammad, Ali Moshfegh, Amir Hossein Daneshmanesh, et al.. (2015). First-in-Class ROR1 Small Molecule Inhibitor (KAN0439834) Downregulated Wnt-Canonical and Non-Canonical Signaling Pathways and Induced Apoptosis of CLL Cells. Blood. 126(23). 2912–2912. 4 indexed citations

15.

Decken, Alexandra von der, Thomas Olin, & Per‐Anders Bergqvist. (1992). Physiological properties of liver, gonads and muscle during maturation of female atlantic salmon, Salmo salar. Comparison between a control and xenobiotics containing fish feed. Comparative Biochemistry and Physiology Part C Comparative Pharmacology. 101(3). 525–529. 3 indexed citations

16.

Olin, Thomas, et al.. (1992). Effect of Dietary Keto Acids on Intermediary Metabolism of Nutrients in Atlantic Salmon (Salmo salar) during 17-β-Estradiol-Induced Vitellogenin Synthesis. Acta Agriculturae Scandinavica Section A – Animal Science. 42(4). 246–253. 8 indexed citations

17.

Olin, Thomas, et al.. (1991). Response of epaxial muscle and liver to 17-β estradiol in fed and starved Atlantic salmon (Salmo salar). Aquaculture. 99(1-2). 179–191. 21 indexed citations

18.

Olin, Thomas & Alexandra von der Decken. (1990). Yolk proteins in salmon (Salmo salar) oocytes, eyed eggs, and alevins differing in viability. Canadian Journal of Zoology. 68(5). 895–900. 24 indexed citations

19.

Olin, Thomas, A. Westman, & Alexandra von der Decken. (1989). Time‐ and temperature‐dependent appearance of vitellogenin in Golgi vesicles and serum after estrogen treatment of salmon (Salmo salar). Journal of Experimental Zoology. 249(2). 213–220. 10 indexed citations

20.

Olin, Thomas & Alexandra von der Decken. (1987). Estrogen Treatment and Its Implication on Vitellogenin and Myosin Synthesis in Salmon (Salmo salar). Physiological Zoology. 60(3). 346–351. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact